Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Vaxcyte, Inc.
  6. News
  7. Summary
    PCVX   US92243G1085

VAXCYTE, INC.

(PCVX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about VAXCYTE, INC.
11/11Vaxcyte to Present at Upcoming Investor Conferences
GL
11/10Vaxcyte Investor Presentation November 2021
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update - For..
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/10Vaxcyte, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
10/28Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
AQ
10/28Vaxcyte, Inc. Announces Board Changes
CI
10/22INSIDER SELL : Vaxcyte
MT
09/28VAXCYTE : to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
AQ
09/21VAXCYTE : to Present at 2021 Cantor Virtual Global Healthcare Conference
AQ
09/20VAXCYTE : Investor Presentation September 2021
PU
09/20Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors
GL
09/20Vaxcyte, Inc. Announces Board Changes
CI
08/11VAXCYTE : Investor Presentation August 2021
PU
08/11VAXCYTE : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form..
PU
More most relevant news
All news about VAXCYTE, INC.
11/11Vaxcyte to Present at Upcoming Investor Conferences
GL
11/10Vaxcyte Investor Presentation November 2021
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update - For..
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/10VAXCYTE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/10Vaxcyte, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
10/28VAXCYTE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/28Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
AQ
10/28Vaxcyte, Inc. Announces Board Changes
CI
10/22INSIDER SELL : Vaxcyte
MT
More news
News in other languages on VAXCYTE, INC.
03/30Vaxcyte réduit sa perte au quatrième trimestre et augmente ses dépenses d'exploitation
03/24Le conseil d'administration de GlaxoSmithKline renvoie Moncef Slaoui, président de Galv..
03/24GlaxoSmithKline licencie le président de l'unité Galvani à la suite d'allégations de ha..
03/24GSK : le Dr Sloaoui licencié pour harcèlement sexuel
2020Vaxcyte nomme Andrew Guggenhime au poste de président
More news
Press releases
11/11Vaxcyte to Present at Upcoming Investor Conferences
GL
11/10Vaxcyte Investor Presentation November 2021
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update - For..
PU
11/10Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
11/10VAXCYTE, INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
More press releases
Upcoming event on VAXCYTE, INC.